Noveris Health Sciences Inc. (CSE:NVRS)
Canada · Delayed Price · Currency is CAD 2.600
+0.160 (6.56%)
At close: Jun 3, 2026
Noveris Health Sciences Company Description
Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality.
The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds.
Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026.
The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Noveris Health Sciences Inc.
| Country | Canada |
| Founded | 2013 |
| Industry | Agricultural Production Crops |
| CEO | Jason Birmingham |
Contact Details
Address: 1075 West Georgia Street Vancouver, BC V6E 3C9 Canada | |
| Phone | 778 900 6877 |
| Website | noveris.health |
Stock Details
| Ticker Symbol | NVRS |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Jason Birmingham | Chief Executive Officer |
| John Ross | Chief Financial Officer |